| |
| |
|
| Insider
Information: |
Bennett C Frank |
| Relationship: |
Officer Level 14 |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
79,462 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,985,387 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
79,462 |
|
|
| Total
Value |
$2,985,387 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -99.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Officer Level 14 |
2024-02-29 |
79,462 |
2003-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
191 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2012-07-01 |
4 |
A |
$6.13 |
$3,971 |
D/D |
648 |
1,277 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2012-07-03 |
4 |
AS |
$12.91 |
$77,460 |
D/D |
(6,000) |
1,277 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2012-07-03 |
4 |
OE |
$6.84 |
$41,040 |
D/D |
6,000 |
7,277 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2012-07-09 |
4 |
OE |
$6.81 |
$71,670 |
D/D |
10,500 |
6,277 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2012-07-09 |
4 |
AS |
$13.51 |
$141,855 |
D/D |
(10,500) |
1,277 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-01-01 |
4 |
A |
$8.87 |
$3,967 |
D/D |
447 |
1,724 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
695 |
2,419 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-01-16 |
4 |
S |
$14.00 |
$4,326 |
D/D |
(309) |
2,110 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-04-30 |
4 |
AS |
$22.51 |
$675,153 |
D/D |
(30,000) |
2,110 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-04-30 |
4 |
OE |
$11.12 |
$333,600 |
D/D |
30,000 |
32,110 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-05-01 |
4 |
OE |
$6.81 |
$230,410 |
D/D |
29,945 |
8,255 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-05-01 |
4 |
AS |
$22.26 |
$666,606 |
D/D |
(29,945) |
2,110 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-07-01 |
4 |
A |
$9.20 |
$6,953 |
D/D |
756 |
2,866 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-09-09 |
4 |
OE |
$15.38 |
$153,800 |
D/D |
10,000 |
12,866 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-09-09 |
4 |
AS |
$30.23 |
$302,250 |
D/D |
(10,000) |
2,866 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-09-19 |
4 |
OE |
$15.38 |
$153,800 |
D/D |
10,000 |
12,866 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-09-19 |
4 |
AS |
$35.02 |
$350,200 |
D/D |
(10,000) |
2,866 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-12-05 |
4 |
OE |
$15.38 |
$153,800 |
D/D |
10,000 |
7,416 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-12-05 |
4 |
AS |
$39.90 |
$399,182 |
D/D |
(10,000) |
2,866 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2014-01-01 |
4 |
A |
$24.20 |
$3,969 |
D/D |
164 |
3,030 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2014-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,110 |
4,601 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2014-01-16 |
4 |
S |
$47.08 |
$37,853 |
D/D |
(804) |
4,336 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2014-06-23 |
4 |
OE |
$15.38 |
$172,256 |
D/D |
11,200 |
9,336 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2014-06-23 |
4 |
AS |
$36.54 |
$411,910 |
D/D |
(11,200) |
4,336 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2014-07-01 |
4 |
A |
$30.20 |
$8,788 |
D/D |
291 |
4,627 |
0 |
- |
|
191 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
